Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $9.39 billion. The enterprise value is $9.29 billion.
| Market Cap | 9.39B |
| Enterprise Value | 9.29B |
Important Dates
The next estimated earnings date is Monday, November 2, 2026, before market open.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 52.38 million shares outstanding. The number of shares has increased by 4.44% in one year.
| Current Share Class | 52.38M |
| Shares Outstanding | 52.38M |
| Shares Change (YoY) | +4.44% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 74.70% |
| Float | 44.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 550.52 |
| PS Ratio | 12.09 |
| Forward PS | 7.83 |
| PB Ratio | 112.54 |
| P/TBV Ratio | 276.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 2.70.
| Current Ratio | 1.43 |
| Quick Ratio | 1.30 |
| Debt / Equity | 2.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.20 |
Financial Efficiency
Return on equity (ROE) is -245.10% and return on invested capital (ROIC) is -38.20%.
| Return on Equity (ROE) | -245.10% |
| Return on Assets (ROA) | -16.31% |
| Return on Invested Capital (ROIC) | -38.20% |
| Return on Capital Employed (ROCE) | -60.75% |
| Weighted Average Cost of Capital (WACC) | 8.05% |
| Revenue Per Employee | $576,946 |
| Profits Per Employee | -$142,380 |
| Employee Count | 1,346 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 1.87 |
Taxes
In the past 12 months, AXSM has paid $558,000 in taxes.
| Income Tax | 558,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.18% in the last 52 weeks. The beta is 0.71, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +51.18% |
| 50-Day Moving Average | 209.41 |
| 200-Day Moving Average | 199.79 |
| Relative Strength Index (RSI) | 28.53 |
| Average Volume (20 Days) | 714,269 |
Short Selling Information
The latest short interest is 3.14 million, so 5.99% of the outstanding shares have been sold short.
| Short Interest | 3.14M |
| Short Previous Month | 3.08M |
| Short % of Shares Out | 5.99% |
| Short % of Float | 7.06% |
| Short Ratio (days to cover) | 5.48 |
Income Statement
In the last 12 months, AXSM had revenue of $776.57 million and -$191.64 million in losses. Loss per share was -$3.76.
| Revenue | 776.57M |
| Gross Profit | 724.04M |
| Operating Income | -182.86M |
| Pretax Income | -191.09M |
| Net Income | -191.64M |
| EBITDA | -172.92M |
| EBIT | -182.86M |
| Loss Per Share | -$3.76 |
Balance Sheet
The company has $319.85 million in cash and $224.69 million in debt, with a net cash position of $95.16 million or $1.82 per share.
| Cash & Cash Equivalents | 319.85M |
| Total Debt | 224.69M |
| Net Cash | 95.16M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 83.30M |
| Book Value Per Share | 1.59 |
| Working Capital | 196.12M |
Cash Flow
In the last 12 months, operating cash flow was -$71.26 million and capital expenditures -$700,000, giving a free cash flow of -$71.96 million.
| Operating Cash Flow | -71.26M |
| Capital Expenditures | -700,000 |
| Depreciation & Amortization | 9.94M |
| Net Borrowing | -3.09M |
| Free Cash Flow | -71.96M |
| FCF Per Share | -$1.37 |
Margins
Gross margin is 93.24%, with operating and profit margins of -23.55% and -24.68%.
| Gross Margin | 93.24% |
| Operating Margin | -23.55% |
| Pretax Margin | -24.61% |
| Profit Margin | -24.68% |
| EBITDA Margin | -22.27% |
| EBIT Margin | -23.55% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.44% |
| Shareholder Yield | -4.44% |
| Earnings Yield | -2.04% |
| FCF Yield | -0.77% |
Analyst Forecast
The average price target for AXSM is $285.22, which is 59.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $285.22 |
| Price Target Difference | 59.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 51.17% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 5.09 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.09 |
| Piotroski F-Score | 3 |